oxidopamine and u 0126

oxidopamine has been researched along with u 0126 in 8 studies

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's4 (50.00)29.6817
2010's4 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Klann, E; Lin, E; Perez, RG; Ugarte, SD; Zigmond, MJ1
Cavanaugh, JE; Jaumotte, JD; Lakoski, JM; Zigmond, MJ1
Chu, CT; Horbinski, C; Kulich, SM; Patel, M1
Cavanaugh, JE; Leak, RK; Lin, E; Perez, RG; Zigmond, MJ1
Greig, NH; Holloway, HW; Li, Y; Mattson, MP; Tweedie, D1
Cui, C; Ding, HF; Fan, Y; Fu, SB; Jiang, LH; Li, J; Ma, L; Sun, DJ; Yang, J; Zhang, YN1
Bagetta, V; Brambilla, R; Calabresi, P; Cerovic, M; Fasano, S; Ghiglieri, V; Giampà, C; Hardingham, N; Heuer, A; Marchisella, F; Morella, I; Papale, A; Pendolino, V; Picconi, B1
Ballerini, P; Buccella, S; Caciagli, F; Ciccarelli, R; D'Alimonte, I; Di Iorio, P; Giuliani, P; Pokorski, M; Rathbone, MP; Romano, S1

Other Studies

8 other study(ies) available for oxidopamine and u 0126

ArticleYear
Effects of GDNF on 6-OHDA-induced death in a dopaminergic cell line: modulation by inhibitors of PI3 kinase and MEK.
    Journal of neuroscience research, 2003, Jul-01, Volume: 73, Issue:1

    Topics: Animals; Butadienes; Cell Death; Cell Line; Cell Survival; Chromones; Dopamine; Enzyme Inhibitors; Glial Cell Line-Derived Neurotrophic Factor; MAP Kinase Signaling System; Mitogen-Activated Protein Kinases; Morpholines; Nerve Growth Factors; Neurons; Neuroprotective Agents; Nitriles; Oxidative Stress; Oxidopamine; Parkinson Disease; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Protein Serine-Threonine Kinases; Sympatholytics

2003
Neuroprotective role of ERK1/2 and ERK5 in a dopaminergic cell line under basal conditions and in response to oxidative stress.
    Journal of neuroscience research, 2006, Nov-01, Volume: 84, Issue:6

    Topics: Blotting, Western; Butadienes; Cell Death; Cell Line; Cell Survival; Culture Media; Dopamine; Enzyme Inhibitors; Humans; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Mitogen-Activated Protein Kinase 7; Nitriles; Oxidative Stress; Oxidopamine; Plasmids; Transfection

2006
6-Hydroxydopamine induces mitochondrial ERK activation.
    Free radical biology & medicine, 2007, Aug-01, Volume: 43, Issue:3

    Topics: Animals; Butadienes; Catalase; Cells, Cultured; Enzyme Activation; Extracellular Signal-Regulated MAP Kinases; Flavonoids; Metalloporphyrins; Mitochondria; Mitogen-Activated Protein Kinase Kinases; Neurons; Nitriles; Oxidopamine; Rats; Signal Transduction

2007
Rapid activation of ERK by 6-hydroxydopamine promotes survival of dopaminergic cells.
    Journal of neuroscience research, 2008, Volume: 86, Issue:1

    Topics: Adrenergic Agents; Analysis of Variance; Animals; Butadienes; Caspase 3; Cell Line, Transformed; Cell Survival; CREB-Binding Protein; Dopamine; Drug Interactions; Enzyme Activation; Enzyme Inhibitors; Extracellular Signal-Regulated MAP Kinases; Mice; Mice, Inbred C57BL; Neurons; Nitriles; Oxidopamine; Phosphorylation; Reactive Oxygen Species; Time Factors

2008
Enhancing the GLP-1 receptor signaling pathway leads to proliferation and neuroprotection in human neuroblastoma cells.
    Journal of neurochemistry, 2010, Volume: 113, Issue:6

    Topics: Activating Transcription Factor 4; Adrenergic Agents; Apoptosis; bcl-2-Associated X Protein; Bromodeoxyuridine; Butadienes; Caspase 3; Cell Line, Tumor; Cell Proliferation; Cell Survival; Colforsin; Cyclic AMP; Dose-Response Relationship, Drug; Enzyme Inhibitors; Exenatide; Glucagon-Like Peptide 1; Glucagon-Like Peptide-1 Receptor; Humans; Hydrogen Peroxide; Hypoglycemic Agents; Neuroblastoma; Neuroprotective Agents; Nitriles; Oxidants; Oxidopamine; Peptides; Proto-Oncogene Proteins c-bcl-2; Receptors, Glucagon; Signal Transduction; Time Factors; Transfection; Venoms

2010
The Raf-1 inhibitor GW5074 and the ERK1/2 pathway inhibitor U0126 ameliorate PC12 cells apoptosis induced by 6-hydroxydopamine.
    Die Pharmazie, 2012, Volume: 67, Issue:8

    Topics: Apoptosis; Bisbenzimidazole; Blotting, Western; Butadienes; Cell Survival; Enzyme Inhibitors; Flow Cytometry; Humans; Indicators and Reagents; Indoles; MAP Kinase Signaling System; Nitriles; Oxidopamine; Parkinson Disease; PC12 Cells; Phenols; Phosphorylation; Proto-Oncogene Proteins c-raf

2012
Derangement of Ras-guanine nucleotide-releasing factor 1 (Ras-GRF1) and extracellular signal-regulated kinase (ERK) dependent striatal plasticity in L-DOPA-induced dyskinesia.
    Biological psychiatry, 2015, Jan-15, Volume: 77, Issue:2

    Topics: Animals; Antiparkinson Agents; Butadienes; Cerebral Cortex; Corpus Striatum; Dopamine; Dyskinesia, Drug-Induced; Extracellular Signal-Regulated MAP Kinases; Levodopa; Mice, Knockout; Neuronal Plasticity; Neurons; Nitriles; Oxidopamine; Parkinsonian Disorders; Protein Kinase Inhibitors; ras-GRF1; Tissue Culture Techniques

2015
Guanosine protects glial cells against 6-hydroxydopamine toxicity.
    Advances in experimental medicine and biology, 2015, Volume: 837

    Topics: Animals; Apoptosis; Astrocytes; Biological Transport; Butadienes; Cell Line, Tumor; Chromones; DNA Fragmentation; Drug Evaluation, Preclinical; Glioma; Guanosine; In Vitro Techniques; MAP Kinase Signaling System; Morpholines; Neuroprotective Agents; Neurotoxins; Nitriles; Nucleoside Transport Proteins; Oxidopamine; Phosphatidylinositol 3-Kinases; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Rats; Signal Transduction

2015
chemdatabank.com